FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Phase III | Tamiflu | flu | Avian Flu | pandemic | Canada

Roche suspends Canadian sales of Tamiflu as demand skyrockets

Tools

Faced with soaring demand for Tamiflu--the antiviral drug that can be used to blunt the onslaught of avian flu--Roche has suspended sales of the drug in Canada. Roche said that it is attempting to conserve supplies for the coming flu season and is worried that stockpiles will be depleted before they're truly needed. Governments around the globe have been clamoring for the drug as they prepare for a possible pandemic.

- read this report from Canada.com for more

PLUS: Roche's MabThera demonstrated positive data in Phase III for lymphoma earlier than expected. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about flu   Avian Flu   pandemic   Canada   Roche   lymphoma   antiviral drug   Phase III   Tamiflu